Clearmind Medicine (CMND) News Today $0.86 -0.03 (-3.07%) As of 03:51 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CMND Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic TherapeuticsJune 12 at 9:25 AM | globenewswire.comClearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder TreatmentJune 5, 2025 | globenewswire.comClearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic ExpertsMay 20, 2025 | globenewswire.comClearmind Medicine files patent for eating disorder treatmentApril 26, 2025 | investing.comClearmind Medicine files patent for eating disorder treatmentApril 26, 2025 | investing.comClearmind Medicine Inc.: Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating DisordersApril 25, 2025 | finanznachrichten.deSciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating DisordersApril 25, 2025 | globenewswire.comClearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating DisordersApril 25, 2025 | globenewswire.comPsychedelic: Clearmind completes clinical site initiations for AUD trialApril 25, 2025 | markets.businessinsider.comClearmind Medicine completes initiation of AUD Phase I/IIa trialApril 24, 2025 | markets.businessinsider.comClearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical SitesApril 23, 2025 | globenewswire.comClearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic ExpertsApril 21, 2025 | globenewswire.comClearmind Medicine begins phase I/IIa trial for AUD treatmentApril 18, 2025 | uk.investing.comClearmind Medicine Inc.: Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge BehaviorApril 17, 2025 | finanznachrichten.deClearmind Medicine launches first U.S. clinical site for AUD trialApril 17, 2025 | markets.businessinsider.comClearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge BehaviorApril 17, 2025 | globenewswire.comClearmind Medicine Inc.: Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat AlcoholismApril 16, 2025 | finanznachrichten.deClearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat AlcoholismApril 16, 2025 | globenewswire.comClearmind Medicine announces U.S. clinical site initiation for CMND-100 trialApril 10, 2025 | markets.businessinsider.comPsychedelic: Clearmind initiates U.S. clinical site for CMND-100 trialApril 10, 2025 | markets.businessinsider.comClearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use DisorderApril 10, 2025 | globenewswire.comClearmind announces patent application for psychedelic-based compoundsApril 8, 2025 | markets.businessinsider.comClearmind Medicine Announces the Publication of International Patent Application for Next-Gen Psychedelic Compounds to Treat Mental Health DisordersApril 8, 2025 | globenewswire.comClearmind launches data system for alcohol addiction trialApril 3, 2025 | uk.investing.comClearmind Medicine launches EDC system to support Phase I/II trialApril 2, 2025 | markets.businessinsider.comClearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based TreatmentApril 1, 2025 | globenewswire.comPsychedelic: Exclusive talk with biotech company Clearmind MedicineMarch 22, 2025 | finance.yahoo.comClearmind Medicine says CMND-100 arrives in the U.S.March 21, 2025 | markets.businessinsider.comClearmind Medicine’s FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key MilestonesMarch 21, 2025 | markets.businessinsider.comClearmind Medicine's FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key MilestonesMarch 21, 2025 | globenewswire.comClearmind begins phase I/IIa trial for AUD treatmentMarch 20, 2025 | uk.investing.comClearmind Medicine Initiates First Clinical Trial Of CMND-100 For Alcohol Use Disorder TreatmentMarch 20, 2025 | nasdaq.comClearmind Medicine Inc.: Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug CombinationMarch 19, 2025 | finanznachrichten.deClearmind Medicine initiates first in human clinical trial with CMND-100March 19, 2025 | markets.businessinsider.comClearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug CombinationMarch 19, 2025 | globenewswire.comClearmind Medicine Announces Initiation of First in Human Clinical Trial with CMND-100 in Alcohol Use Disorder PatientsMarch 18, 2025 | globenewswire.comPsychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trialMarch 13, 2025 | markets.businessinsider.comClearmind announces patent publication for cocaine addiction treatment by KIPOMarch 10, 2025 | markets.businessinsider.comClearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South KoreaMarch 10, 2025 | markets.businessinsider.comClearmind announces publication of patent for binge behavior treatmentFebruary 4, 2025 | markets.businessinsider.comClearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in MexicoFebruary 4, 2025 | globenewswire.comClearmind Medicine announces publication of European patent applicationJanuary 7, 2025 | markets.businessinsider.comClearmind Medicine Announces Shareholders Meeting ResultsJanuary 7, 2025 | globenewswire.comClearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination TreatmentJanuary 6, 2025 | globenewswire.comClearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property OfficeJanuary 2, 2025 | globenewswire.comClearmind Medicine to move forward with MEAI-based alcohol substituteDecember 27, 2024 | markets.businessinsider.comClearmind Medicine Inc.: Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical TrialDecember 26, 2024 | finanznachrichten.deClearmind To Partner With Dr Glitter To Advance Development Of MEAI As Safe Alternative To AlcoholDecember 26, 2024 | markets.businessinsider.comClearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol SubstituteDecember 26, 2024 | globenewswire.comClearmind Medicine Shares Double on Trial ApprovalDecember 24, 2024 | marketwatch.com Get Clearmind Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for CMND and its competitors with MarketBeat's FREE daily newsletter. Email Address CMND Media Mentions By Week CMND Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMND News Sentiment▼1.210.87▲Average Medical News Sentiment CMND News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMND Articles This Week▼21▲CMND Articles Average Week Get Clearmind Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for CMND and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PMN News Today GOVX News Today PRPH News Today LPTX News Today VYNE News Today ALVR News Today FLGC News Today MEIP News Today BLRX News Today EDSA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CMND) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearmind Medicine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearmind Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
